These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12546947)

  • 1. The dilemma of process development.
    Shultis K
    Drug Discov Today; 2002 Aug; 7(16):850-3. PubMed ID: 12546947
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
    Kelly WJ
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 5. Data completeness--the Achilles heel of drug-target networks.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Nat Biotechnol; 2008 Sep; 26(9):983-4. PubMed ID: 18779805
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic peptide API manufacturing: A mini review of current perspectives for peptide manufacturing.
    Rasmussen JH
    Bioorg Med Chem; 2018 Jun; 26(10):2914-2918. PubMed ID: 29735426
    [No Abstract]   [Full Text] [Related]  

  • 7. An automated modular assembly line for drugs in a miniaturized plant.
    Hu C; Testa CJ; Wu W; Shvedova K; Shen DE; Sayin R; Halkude BS; Casati F; Hermant P; Ramnath A; Born SC; Takizawa B; O'Connor TF; Yang X; Ramanujam S; Mascia S
    Chem Commun (Camb); 2020 Jan; 56(7):1026-1029. PubMed ID: 31854390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs.
    Wolfson W
    Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292
    [No Abstract]   [Full Text] [Related]  

  • 9. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic reactor design approach for the synthesis of active pharmaceutical ingredients.
    Emenike VN; Schenkendorf R; Krewer U
    Eur J Pharm Biopharm; 2018 May; 126():75-88. PubMed ID: 28536050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 12. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 15. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 16. Europe's sweeping chemical law puts medicines in peril.
    Keim B
    Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17297677
    [No Abstract]   [Full Text] [Related]  

  • 17. Large-scale oxidations in the pharmaceutical industry.
    Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
    Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting your best mode forward.
    Tsao YR; Tabtiang RK
    Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.